JS, A., A, M., J, S., & MS, M. (2026). Risk of developing hematologic malignancy in patients with autoimmune and inflammatory skin diseases. Journal of the American Academy of Dermatology, 94(2), 588. https://doi.org/10.1016/j.jaad.2025.09.075
Chicago Style (17th ed.) CitationJS, Arora, Mahadevan A, Smith J, and Min MS. "Risk of Developing Hematologic Malignancy in Patients with Autoimmune and Inflammatory Skin Diseases." Journal of the American Academy of Dermatology 94, no. 2 (2026): 588. https://doi.org/10.1016/j.jaad.2025.09.075.
MLA (9th ed.) CitationJS, Arora, et al. "Risk of Developing Hematologic Malignancy in Patients with Autoimmune and Inflammatory Skin Diseases." Journal of the American Academy of Dermatology, vol. 94, no. 2, 2026, p. 588, https://doi.org/10.1016/j.jaad.2025.09.075.